Compare PED & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PED | VNRX |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.7M | 31.9M |
| IPO Year | 2012 | 2012 |
| Metric | PED | VNRX |
|---|---|---|
| Price | $16.47 | $0.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $30.00 | $2.50 |
| AVG Volume (30 Days) | 827.2K | ★ 1.5M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 38.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $39,553,000.00 | $1,233,511.00 |
| Revenue This Year | N/A | $68.22 |
| Revenue Next Year | $305.89 | $382.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 28.49 | ★ 59.10 |
| 52 Week Low | $0.43 | $0.17 |
| 52 Week High | $18.89 | $0.94 |
| Indicator | PED | VNRX |
|---|---|---|
| Relative Strength Index (RSI) | 88.65 | 36.71 |
| Support Level | $0.54 | $0.17 |
| Resistance Level | N/A | $0.27 |
| Average True Range (ATR) | 0.47 | 0.02 |
| MACD | 1.64 | 0.00 |
| Stochastic Oscillator | 85.71 | 5.36 |
PEDEVCO Corp is an oil and gas company focused on oil and natural gas development, exploration, and production. The company focuses on legacy properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin, situated in West Texas and eastern New Mexico (the Permian Basin), and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.